Novavax, Inc (NVAX) recent activity suggests a positive outlook with the last week’s performance of -9.76%

On Tuesday, Novavax, Inc (NASDAQ: NVAX) was -4.10% drop from the session before settling in for the closing price of $8.77. A 52-week range for NVAX has been $3.53 – $23.86.

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 513.29%. When this article was written, the company’s average yearly earnings per share was at 73.75%. With a float of $153.02 million, this company’s outstanding shares have now reached $160.15 million.

The extent of productivity of a business whose workforce counts for 1543 workers is very important to gauge. In terms of profitability, gross margin is 66.75%, operating margin of -33.36%, and the pretax margin is -31.6%.

Novavax, Inc (NVAX) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Novavax, Inc stocks. The insider ownership of Novavax, Inc is 4.47%, while institutional ownership is 58.98%. The most recent insider transaction that took place on Sep 18 ’24, was worth 95,331. Before that another transaction happened on Jun 21 ’24, when Company’s Director sold 7,500 for $14.09, making the entire transaction worth $105,675. This insider now owns 61,760 shares in total.

Novavax, Inc (NVAX) Latest Financial update

Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.44 earnings per share (EPS) during the time that was less than consensus figure (set at -0.45) by -0.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 73.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.90% during the next five years compared to 11.55% growth over the previous five years of trading.

Novavax, Inc (NASDAQ: NVAX) Trading Performance Indicators

You can see what Novavax, Inc (NVAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.52.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.26, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach 0.10 in one year’s time.

Technical Analysis of Novavax, Inc (NVAX)

The latest stats from [Novavax, Inc, NVAX] show that its last 5-days average volume of 3.12 million was inferior to 9.52 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 54.06%. Additionally, its Average True Range was 0.63.

During the past 100 days, Novavax, Inc’s (NVAX) raw stochastic average was set at 14.55%, which indicates a significant decrease from 59.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.36% in the past 14 days, which was lower than the 100.15% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $10.32, while its 200-day Moving Average is $10.27. Now, the first resistance to watch is $8.69. This is followed by the second major resistance level at $8.97. The third major resistance level sits at $9.14. If the price goes on to break the first support level at $8.24, it is likely to go to the next support level at $8.07. The third support level lies at $7.79 if the price breaches the second support level.

Novavax, Inc (NASDAQ: NVAX) Key Stats

There are 160,185K outstanding shares of the company, which has a market capitalization of 1.35 billion. As of now, sales total 983,710 K while income totals -545,060 K. Its latest quarter income was 84,510 K while its last quarter net income were -121,300 K.